Le Lézard
Classified in: Health
Subject: PLW

ResMed's European Patents Infringed by Fisher & Paykel in Germany



SAN DIEGO, Oct. 6, 2017 /PRNewswire/ -- ResMed (NYSE: RMD) the world's leading tech-driven medical device company and innovator in sleep-disordered breathing and respiratory care, today announced the following updates in its ongoing global patent infringement litigation with Fisher & Paykel:

"ResMed will continue to stand against those we believe have unlawfully violated our patents," said ResMed global general counsel and chief administrative officer David Pendarvis. "We have more than 5,000 patents in our portfolio, reflecting three decades and millions of dollars of sustained investment in research and development, focused on ensuring that patients around the world receive the high-quality care they deserve. We're confident, as we've seen in these early rulings, that ResMed will ultimately prevail against Fisher & Paykel."

About ResMed

ResMed (NYSE: RMD) changes lives with award-winning medical devices and cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed is a global leader in connected care, with more than 3 million patients remotely monitored every day. Our 6,000-strong team is committed to creating the world's best tech-driven medical device company ? improving quality of life, reducing the impact of chronic disease, and saving healthcare costs in more than 120 countries. ResMed.com | Facebook | Twitter | LinkedIn

For media:

For investors:

Alison Graves

Agnes Lee

+1 858-836-6789

+1 858-836-5971

news@resmed.com 

investorrelations@resmed.com





ResMed Inc. logo. (PRNewsFoto/ResMed Inc.)

 

SOURCE ResMed Inc.


These press releases may also interest you

at 11:25
When it comes to providing quality education to its members, Mississippi Hospital Association (MHA) feels there is no such thing as too much, which is why they have invited Wound Care Education Institute® (WCEI®) to Madison, Mississippi to teach the...

at 11:12
Paragon Bioservices, a global leader in the manufacturing of biopharmaceuticals and vaccines, is proud to be a recipient of BBJ's Fast 50 Award this year.  On November 29th, the Baltimore Business Journal hosted the...

at 11:11
There are 50 key biotechnology companies that are shaping the biotherapeutics market in 2017 and beyond, according to Kalorama Information. The biotherapeutics sector, composed of biopharmaceuticals and biotechnology, is the fastest growing sector in...

at 11:05
The Center for Plain Language is speaking out against proposed changes to the Centers for Disease Control and Prevention's (CDC) communication rules. On Friday, December 15, the Washington Post reported that the Trump administration is forbidding CDC...

at 11:05
Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA), a leading advisory firm and Clinical Research Organization (CRO) to the medical device industry, is pleased to announce that it delivered an informational presentation about United States...

at 11:03
Further to a December 5th press release announcing plans to establish a 40,000 m2 facility in the Danish city of Odense, Spectrum Cannabis Denmark has been issued a cannabis production licence by Laegemiddelstyrelsen, Denmark's Medicines Agency....




News published on 6 october 2017 at 04:53 and distributed by: